Adverse effects of intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs in eyes with RP have not been reported, whether this therapy was to treat CNV [2, 3] or cystoid macular edema [10, 11]. This evidence concerns the gene VEGFA and retinitis pigmentosa 1.